Successful Control of Massive Bleeding in a Child with Burkitt’s Lymphoma via a Biosimilar Recombinant Activated Factor VII (AryoSeven<i>™</i>)

<table class="table-group" id="tab4"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td class="align_left">Lab data </td><td class="align_center">12 hours after AryoSeven<i>™</i> injection</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td class="align_left">WBC</td><td class="align_center">3880/mm<sup>3</sup></td></tr><tr><td class="align_left">Hb</td><td class="align_center">11.7 g/dL</td></tr><tr><td class="align_left">Plt</td><td class="align_center">65000/mm<sup>3</sup></td></tr><tr><td class="align_left">PT </td><td class="align_center">12 seconds</td></tr><tr><td class="align_left">PTT</td><td class="align_center">34 seconds</td></tr><tr><td class="align_left">FDP and D-Dimer</td><td class="align_center">Normal</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Lab data 12 hours after administration of AryoSeven.

Case Reports in Hematology

tab4

Table 4

Table 4: Successful Control of Massive Bleeding in a Child with Burkitt’s Lymphoma via a Biosimilar Recombinant Activated Factor VII (AryoSeven<i>™</i>) 

Case Reports in Hematology

Successful Control of Massive Bleeding in a Child with Burkitt’s Lymphoma via a Biosimilar Recombinant Activated Factor VII (AryoSeven™)

Table 4